433 related articles for article (PubMed ID: 21566546)
1. Health-related quality of life in psoriasis: an analysis of Psocare project patients.
Spandonaro F; Altomare G; Berardesca E; Calzavara-Pinton P; Chimenti S; Girolomoni G; Peserico A; Guerra AP; Vena GA; Polistena B; Ayala F
G Ital Dermatol Venereol; 2011 Jun; 146(3):169-77. PubMed ID: 21566546
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
Tang MM; Chang CC; Chan LC; Heng A
Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
[TBL] [Abstract][Full Text] [Related]
3. Willingness-to-pay and quality of life in patients with vitiligo.
Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
[TBL] [Abstract][Full Text] [Related]
4. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone.
Rosen CF; Mussani F; Chandran V; Eder L; Thavaneswaran A; Gladman DD
Rheumatology (Oxford); 2012 Mar; 51(3):571-6. PubMed ID: 22157469
[TBL] [Abstract][Full Text] [Related]
5. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life.
Katugampola RP; Hongbo Y; Finlay AY
Br J Dermatol; 2005 Jun; 152(6):1256-62. PubMed ID: 15948990
[TBL] [Abstract][Full Text] [Related]
6. Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.
Norlin JM; Steen Carlsson K; Persson U; Schmitt-Egenolf M
Br J Dermatol; 2012 Apr; 166(4):797-802. PubMed ID: 22182212
[TBL] [Abstract][Full Text] [Related]
7. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
[TBL] [Abstract][Full Text] [Related]
8. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.
Schöffski O; Augustin M; Prinz J; Rauner K; Schubert E; Sohn S; Reich K
J Dtsch Dermatol Ges; 2007 Mar; 5(3):209-18. PubMed ID: 17338796
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis has a major secondary impact on the lives of family members and partners.
Eghlileb AM; Davies EE; Finlay AY
Br J Dermatol; 2007 Jun; 156(6):1245-50. PubMed ID: 17459044
[TBL] [Abstract][Full Text] [Related]
10. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of etanercept in the management of chronic plaque psoriasis.
Lloyd A; Reeves P; Conway P; Reynolds A; Baxter G
Br J Dermatol; 2009 Feb; 160(2):380-6. PubMed ID: 18808413
[TBL] [Abstract][Full Text] [Related]
12. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.
Bergstrom KG; Arambula K; Kimball AB
Cutis; 2003 Nov; 72(5):407-11. PubMed ID: 14655784
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.
Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A
Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951
[TBL] [Abstract][Full Text] [Related]
14. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis.
Sampogna F; Chren MM; Melchi CF; Pasquini P; Tabolli S; Abeni D;
Br J Dermatol; 2006 Feb; 154(2):325-31. PubMed ID: 16433804
[TBL] [Abstract][Full Text] [Related]
15. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis affects patient's quality of life more seriously in female than in male in Japan.
Mabuchi T; Yamaoka H; Kojima T; Ikoma N; Akasaka E; Ozawa A
Tokai J Exp Clin Med; 2012 Sep; 37(3):84-8. PubMed ID: 23032250
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and related factors in a cohort of plaque-type psoriasis patients in La Coruña, Spain.
Fernández-Torres RM; Pita-Fernández S; Fonseca E
Int J Dermatol; 2014 Nov; 53(11):e507-11. PubMed ID: 25266080
[TBL] [Abstract][Full Text] [Related]
18. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
Chaptini C; Quinn S; Marshman G
Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
[TBL] [Abstract][Full Text] [Related]
19. Comorbidities and health-related quality of life in Spanish patients with moderate to severe psoriasis: a cross-sectional study (Arizona study).
Sanchez-Carazo JL; López-Estebaranz JL; Guisado C
J Dermatol; 2014 Aug; 41(8):673-8. PubMed ID: 24942203
[TBL] [Abstract][Full Text] [Related]
20. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
